National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ibuprofen
A propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic effects. Ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Motrin
Chemical structure names:
  • benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-
  • p-isobutylhydratropic acid



Previous:Hytone, I 131 monoclonal antibody CC49, IAP inhibitor HGS1029, ibandronate sodium, ibritumomab tiuxetan
Next:IC-GREEN, ICE regimen, Idamycin, idarubicin, idiotype-pulsed autologous dendritic cell vaccine APC8020

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov